This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
You must register to attend a NewCo Festival.  All sessions have limited capacity.  

Be mindful of transportation time between sessions and remember you can sort by neighborhood. 

To learn how to navigate the schedule and see social features: check out this short video.  
View analytic
Wednesday, October 22 • 4:00pm - 5:00pm
Glooko Inc OPEN

Log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Session Description: Using Health Technology for Chronic Disease Management: In this session, Glooko's CEO Rick Altinger will discuss the current and future role of health technology in chronic disease management, emphasizing Glooko's technology and vision for diabetes management globally. In addition, Rick will discuss Glooko's evolution from a 'mobile app' to an end-to-end 'diabetes management system' being recognized by major insurance and medical device companies.


Rick Altinger

CEO, Glooko Inc

Host Companies

Wednesday October 22, 2014 4:00pm - 5:00pm
Glooko Inc 420 Florence St., Suite 200, Palo Alto, California, 94301
  • Company Description Glooko is an innovative Silicon Valley company that delivers a mobile and cloud based, diabetes & chronic disease management system designed to improve health outcomes for people with diabetes and reduce the costs associated with diabetes population management. Glooko’s analytics and care management system includes direct integration to all major glucose meters and other health devices to supply timely, verified patient data such as blood glucose, carbs, insulin, activity, blood pressure, and weight data. Glooko executes diabetes-centric analytics and supplies standardized reports, risk flags and insights to case managers and Providers via API’s and web-based tools. Glooko was founded in 2010 by technologist Yogen Dalal, mobile app developer Sundeep Madra, and Chamath Palihapitiya, then a Facebook senior executive. Endocrinologist Michael S. Greenfield, M.D., is chief medical officer. In addition to the founders, investors include Samsung Venture Investment Corporation, Social + Capital Partnership, Lifeforce Ventures, Judy Estrin, and Dr. Russell Hirsch.

Attendees (34)